Rankings
▼
Calendar
ANIK FY 2022 Earnings — Anika Therapeutics, Inc. Revenue & Financial Results | Market Cap Arena
ANIK
Anika Therapeutics, Inc.
$213M
FY 2022 Earnings
Healthcare
Medical - Devices
Income Statement
Revenue
$114M
-23.0% YoY
Gross Profit
$73M
64.3% margin
Operating Income
$4M
3.2% margin
Net Income
-$15M
-13.1% margin
EPS (Diluted)
$-1.02
Cash Flow
Operating Cash Flow
$4M
Free Cash Flow
-$3M
Stock-Based Comp.
$14M
Balance Sheet
Total Assets
$349M
Total Liabilities
$64M
Stockholders' Equity
$286M
Cash & Equivalents
$86M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$114M
$148M
-23.0%
Gross Profit
$73M
$83M
-11.7%
Operating Income
$4M
$3M
+40.3%
Net Income
-$15M
$4M
-459.4%
← Q4 2021
All Quarters
Q1 2022 →